<DOC>
	<DOC>NCT02921009</DOC>
	<brief_summary>This study will investigate the effectiveness of fluence rates and treatment times of Corneal Cross Linking other than the original FDA approved protocol of 3mw/cm2.</brief_summary>
	<brief_title>McNeel Eye Center Corneal Crosslinking Study</brief_title>
	<detailed_description>Patient recruitment will include individuals from 18 years to 35 years old with established keratoconus. Transepithelial riboflavin .1% will be applied every three minutes for 30 minutes or until complete corneal penetration is observed. Then the cornea will be irradiated with UV light at fluence rates of 15mw/cm2 for 8 minutes or 30 mw/cm2 for 4 minutes. Post procedural evaluation will take place at day one, day 7 day 30, day 90, day 180 and day 365. Pretreatment keratography will be compared at follow up days beginning on day 30.</detailed_description>
	<mesh_term>Keratoconus</mesh_term>
	<criteria>Males or females between the ages of 15 and 35 with keratoconus diagnosed topographically without other corneal ectatic disease. Prior corneal transplantation, prior corneal refractive surgery.</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>